BofA begins Biohaven at purchase, cites “fast-follower” strategy (NYSE:BHVN)
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase score, citing its drug growth applications for temper and autoimmune…
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase score, citing its drug growth applications for temper and autoimmune…